NDC 68382-569 – Acamprosate calcium

Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Oral

Human Prescription Drug

Product NDC68382-569

Product details

Brand name
Acamprosate calcium
Generic name
Acamprosate calcium
Labeler
Zydus Pharmaceuticals (USA) Inc.
Dosage form
Tablet, Delayed Release
Route
Oral
Marketing category
ANDA · ANDA205995
Marketed since
June 1, 2017
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Acamprosate Calcium →

Package NDC codes (6)

Package NDCDescriptionSince
68382-569-01100 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-569-01)Jun 1, 2017
68382-569-05500 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-569-05)Jun 1, 2017
68382-569-0630 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-569-06)Jun 1, 2017
68382-569-101000 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-569-10)Jun 1, 2017
68382-569-1690 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-569-16)Jun 1, 2017
68382-569-28180 TABLET, DELAYED RELEASE in 1 BOTTLE (68382-569-28)Jun 1, 2017

Other Acamprosate Calcium products